Veradermics, Incorporated
$106.75
-$1.93 (-1.78%)
$104.54Day Range$109.30
Key Statistics
Market Cap
$4.54B
Shares Outstanding
41.8M
Primary Exchange
XNYS
Currency
USD
Type
CS
IPO Date
Feb 4, 2026
Round Lot
100
Locale
US
Trading Data
Day Open
$109.30
Day High
$109.30
Day Low
$104.54
Volume
1.87M
VWAP
$106.59
Prev Close
$108.68
Transactions
--
Acc. Volume
--
About Veradermics, Incorporated
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
PHARMACEUTICAL PREPARATIONSSIC 283421 employees470 JAMES STREET, NEW HAVEN, CT, 06513228.372.3376IPO Feb 4, 2026US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001827635
- Composite FIGI
- BBG00Z1S1G39
- Share Class FIGI
- BBG00Z1S1G48
- Ticker Root
- MANE
- SIC Code
- 2834
About Veradermics, Incorporated (MANE) Stock
Veradermics, Incorporated (MANE) closed the 2026-09-18 session at $106.75, down 1.78% versus the previous close (-1.93). The stock opened at $109.30 and traded between $104.54 and $109.30 during that session. Session trading volume was 1.9M shares. The volume-weighted average price (VWAP) is $106.59.
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
Veradermics, Incorporated has a market capitalization of $4.54 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. MANE is listed on the XNYS exchange. The company employs approximately 21 people. Veradermics, Incorporated is headquartered in NEW HAVEN, CT. The recorded listing date is 2026-02-04.
On this page you can find market MANE stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.